deltatrials
Not Yet Recruiting OBSERVATIONAL NCT06704542

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

A Study of the Impact of Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation Donors on Recipients' Post-Transplant Survival Outcomes: A Multicenter Retrospective Cohort Study Based on HIS Data

Sponsor: Ruijin Hospital

Conditions ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION Diabetes Mellitus Impaired Fasting Glucose
Updated 2 times since 2024 Last updated: Nov 24, 2024 Started: Nov 30, 2024 Primary completion: Apr 30, 2025 Completion: Apr 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION and Diabetes Mellitus, this trial is actively recruiting participants. The trial is conducted by Ruijin Hospital and has accumulated 2 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotNot Yet Recruiting~Sep 2025 – present · 12 months · monthly snapshotNot Yet Recruiting

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Not Yet Recruiting

  2. Dec 2024 — Sep 2025 [monthly]

    Not Yet Recruiting

    First recorded

Nov 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ruijin Hospital
Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations